-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Pacira BioSciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2024.
- Pacira BioSciences, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $2.92M, a 83.5% decline year-over-year.
- Pacira BioSciences, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was $20.9M, a 43.4% decline year-over-year.
- Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2024 was $36.5M, a 84.6% increase from 2023.
- Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $19.7M.
- Pacira BioSciences, Inc. annual Income Tax Expense (Benefit) for 2022 was -$2.61M, a 118% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)